MedImmune Forms Research Partnership MedImmune Inc. will pay a New Jersey biotech company \$15 million to collaborate with it on potential new treatments for autoimmune diseases, starting with lupus. &lt;FONT face="verdana,MS Sans Serif,arial,helvetica" size="-2" color="#666666"&gt;&lt;B&gt;- The Washington Post&lt;/b&gt;&lt;/font&gt;